Long COVID
Conditions
Interventions
SARS-CoV-2 pre-infection population group:none
SARS-CoV-2 post-infection population group:none
Sponsors
People's Hospital of Ningxia Hui Autonomous Region
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Patients with a combination of cardiopulmonary assessment, cognitive assessment, depression assessment, anxiety assessment, laboratory tests, neurological examinations such as lung CT and cranial MRI scans, and with a clinical diagnosis of neocoronary sequelae due to degenerative changes in the function of the central nervous system (diagnosed by at least two senior specialists); 2. All included individuals must have a test for plasma hyaluronic acid;
Exclusion criteria
Exclusion criteria: 1. Patients not associated with neurodegenerative disease; 2. Valid data on plasma hyaluronic acid expression levels in the study could not be obtained; 3. Valid data are in doubt, e.g., the index test method and judging criteria are unknown; 4. Incomplete or inaccurate quantitative data (i.e., exact proportions of the primary outcome are not provided); 5. Patients who had symptoms such as fatigue and cognitive impairment prior to infection with novel coronavirus; 6. Other factors that the investigator considers inappropriate for this trial, or conditions that may increase the risk to the subject or interfere with the study of this project.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| hyaluronic acid;single nucleotide polymorphism,SNP; | — |
Countries
China
Contacts
Public ContactLi Yinshan
People's Hospital of Ningxia Hui Autonomous Region
Outcome results
None listed